Inventor · disambiguated record
Avak Kahvejian
Also filed as: KAHVEJIAN AVAK
31 granted patents·72 pending applications·332 citations·filing 2006–2025
97Inventor score
Files withRUBIUS THERAPEUTICS INC41FLAGSHIP PIONEERING INNOVATIONS V INC26FLAGSHIP PIONEERING INNOVATIONS VI LLC26FLAGSHIP PIONEERING INNOVATIONS VII LLC5FLAGSHIP PIONEERING INC2
Top patents by PatentIndex Score
103 records- 0198US9644180B2Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2015·Granted May 9, 2017·98 cites·21 claims
- 0297US10344263B2Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2017·Granted Jul 9, 2019·14 cites·25 claims
- 0397US10329531B2Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2017·Granted Jun 25, 2019·18 cites·29 claims
- 0497US10253296B2Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2017·Granted Apr 9, 2019·16 cites·24 claims
- 0596US11458156B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Oct 4, 2022·10 cites·30 claims
- 0696US11160822B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Nov 2, 2021·10 cites·30 claims
- 0796US11058706B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2021·Granted Jul 13, 2021·17 cites·30 claims
- 0896US10953033B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2019·Granted Mar 23, 2021·19 cites·36 claims
- 0996US10301594B1Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2018·Granted May 28, 2019·11 cites·29 claims
- 1095US11844759B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2022·Granted Dec 19, 2023·2 cites·30 claims
- 1195US10683352B1Methods for treating cancer using GRM8 inhibitorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted Jun 16, 2020·20 cites·1 claims
- 1295US10301593B2Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2018·Granted May 28, 2019·8 cites·27 claims
- 1394US11034751B1Methods and compositions for treating cancer using serotonin receptor inhibitorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted Jun 15, 2021·17 cites·15 claims
- 1494US10456421B2Compositions and methods related to engineered erythoid cells comprising 4-1BBLRUBIUS THERAPEUTICS INC·Filed 2017·Granted Oct 29, 2019·10 cites·20 claims
- 1593US11446344B1Anellovirus compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2021·Granted Sep 20, 2022·21 cites·29 claims
- 1693US10869898B2Methods and compositions for immunomodulationRUBIUS THERAPEUTICS INC·Filed 2015·Granted Dec 22, 2020·6 cites·25 claims
- 1792US10557119B2Erythroid cells comprising phenylalanine ammonia lyaseRUBIUS THERAPEUTICS INC·Filed 2019·Granted Feb 11, 2020·4 cites·27 claims
- 1892US10517897B1Methods related to engineered erythoid cells comprising 4-1BBLRUBIUS THERAPEUTICS INC·Filed 2019·Granted Dec 31, 2019·4 cites·28 claims
- 1991US11166996B2Anellovirus compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted Nov 9, 2021·12 cites·66 claims
- 2090US10568910B2Compositions and methods related to engineered erythroid cells comprising IL-15RUBIUS THERAPEUTICS INC·Filed 2018·Granted Feb 25, 2020·3 cites·18 claims
- 2188US10457740B1Methods and compositions for treating cancer using P2RX2 inhibitorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2018·Granted Oct 29, 2019·6 cites·1 claims
- 2288US2024122959A1Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Application pending·0 cites
- 2387US12357653B2Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2018·Granted Jul 15, 2025·1 cites·16 claims
- 2487US2025381211A1Compositions comprising circular polyribonucleotides and uses thereofFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2025·Application pending·0 cites
- 2586US11208475B1Methods and compositions for treating inflammatory or autoimmune diseases or conditions using serotonin receptor activatorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted Dec 28, 2021·3 cites·10 claims
- 2683US2023293588A1Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Cancer IndicationsRUBIUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2780US11059886B1Methods and compositions for treating inflammatory or autoimmune diseases or conditions using GRM8 activatorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted Jul 13, 2021·1 cites·20 claims
- 2878US2022072048A1Compositions and Methods Related to Multimodal Therapeutic Cell Systems for Autoimmune IndicationsRUBIUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2977US11013717B1Methods and compositions for treating cancer using SERCA pump inhibitorsFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2019·Granted May 25, 2021·1 cites·10 claims
- 3075US10716811B2Compositions and methods related to multimodal therapeutic cancer indicationsRUBIUS THERAPEUTICS INC·Filed 2018·Granted Jul 21, 2020·0 cites·20 claims
- 3175US2020002674A1Erythroid cells comprising phenylalanine hydroxylaseRUBIUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3275US2023279423A1Compositions comprising curons and uses thereofFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 3375US2019309262A1Erythroid cells comprising serine dehydrataseRUBIUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3475US2019309261A1Erythroid cells comprising lysine oxidaseRUBIUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3575US2019316091A1Erythroid cells comprising arginaseRUBIUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3675US2019376034A1Platelets comprising exogenous polypeptides and uses thereofRUBIUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3775US2019316090A1Erythroid cells comprising arginine deiminaseRUBIUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3874US2019388473A1Methods and compositions for immunomodulationRUBIUS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3972US2018216067A1Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4072US2018265847A1Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4171US12282499B1Database processing system for determining whether an entity affects a transitionFLAGSHIP PIONEERING INNOVATIONS VI LLC·Filed 2023·Granted Apr 22, 2025·0 cites·15 claims
- 4271US2015182588A1Synthetic membrane-receiver complexesVL26 INC·Filed 2014·Application pending·0 cites
- 4371US2020129556A1Compositions and methods related to engineered erythroid cells comprising il-15RUBIUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4471US2018187153A1Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4571US2018187154A1Synthetic membrane-receiver complexesRUBIUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4670US2022362315A1Anellovirus compositions and methods of useFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2022·Application pending·0 cites
- 4770US2018187155A1Compositions and methods related to multimodal therapeutic cell systems for autoimmune indicationsRUBIUS THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4869US2021177823A1Neuromodulating compositions and related therapeutic methods for the treatment of cancerFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 4969US2021154272A1Neuromodulating compositions and related therapeutic methods for the treatment of cancer by modulating an anti-cancer immune responseFLAGSHIP PIONEERING INNOVATIONS V INC·Filed 2020·Application pending·0 cites
- 5068US2022073875A1Amplifiable RNAs for Therapeutic Cell SystemsRUBIUS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
Showing the top 50 of 103 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Avak Kahvejian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →